• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NALU MEDICAL, INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NALU MEDICAL, INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number 71020
Medical Device Problem Code Use of Device Problem (1670)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/12/2025
Type of Reportable Event Serious Injury
Event or Problem Description
A nalu peripheral nerve stimulator system was implanted on (b)(6) 2025 to treat shoulder pain.The patient had participated in a successful trial phase with nalu as well as a wear study prior to implanting the permanent system.The patient chose a location on the front clavicle area to place the implantable pulse generator (ipg) with the leads planning to target bilateral suprascapular nerves.Prior to the implant procedure, the physician and nalu representative performed measurements and the physician determined that 40cm leads would be used.Upon begining the procedure, the physician discovered that the chosen 40cm leads were not sufficient to reach from the nerve target to the patient's chosen ipg location.The physician consulted with the patient's spouse and placed the ipg in the posterior shoulder area instead of the front of the shoulder.The patient reported dissatisfaction with the location of the ipg and requested to revise the system to place the ipg at the original requested location.On (b)(6) 2025 the ipg was removed from the posterior shoulder and placed in the anterior clavicle area.Lead extensions were introduced to accomodate the new ipg location.No components were explanted or replaced and all original components remain implanted and in use with the addition of lead extensions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NALU NEUROSTIMULATION SYSTEM
Common Device Name
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad CA 92008
Manufacturer (Section G)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad CA 92008 7241
Manufacturer Contact
chelsea gutierrez
2320 faraday ave
suite 100
carlsbad, CA 92008-7241
7144010608
MDR Report Key22881256
Report Number3015425075-2025-00258
Device Sequence Number9971721
Product Code GZF
UDI-Device Identifier00812537036182
UDI-Public(01)00812537036182(11)240123(17)270123
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K183579
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 08/22/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model Number71020
Device Catalogue Number71020
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/12/2025
Initial Report FDA Received Date08/23/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured01/23/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-